Transcatheter aortic valve replacement: clinical aspects and ethical considerations.
Matthew L Stone, John A Kern, Robert M Sade
https://pubmed.ncbi.nlm.nih.gov/23176901Actively Recruiting
Led by Universitair Ziekenhuis Brussel · Updated on 2024-12-09
20
Participants Needed
1
Research Sites
N/A
Total Duration
Aortic stenosis is a common condition as people age, especially after age 75, and can lead to serious symptoms and high mortality without treatment. This research investigates hypothyroidism occurring after trans-catheter aortic valve replacement (TAVI), a less invasive alternative to surgery for high-risk or frail elderly patients. The study aims to prospectively identify how often hypothyroidism develops after TAVI and what factors like thyroid disease or medications might predict it, as well as how hypothyroidism affects patients' overall health and function. The study involves elderly patients undergoing the TAVI procedure, which improves heart function by replacing the aortic valve through a catheter. Before and after TAVI, patients receive diagnostic tests including blood samples to assess thyroid function and iodine exposure. The study monitors thyroid hormone levels and antibodies at baseline and up to 12 weeks post-procedure to detect hypothyroidism and its causes. Researchers also evaluate the impact of hypothyroidism on patients' dependence, cognitive function, mood, mobility, and daily living during the first month after TAVI. Participants will have blood and urine tests at specific intervals to measure thyroid hormones and iodine levels, along with ultrasound imaging of the thyroid. Assessments of physical and mental health are performed before TAVI and one month after to understand hypothyroidism's effects. The main outcomes include how many patients develop hypothyroidism and the role of underlying thyroid conditions or iodine exposure. The study follows patients over several weeks to gather detailed information on thyroid health and related functional changes after TAVI.
CONDITIONS
Hypothyroidism After the TAVI Procedure in Elderly Patients
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants undergo thyroid function assessments including blood samples for thyroid hormones and antibodies, thyroid ultrasound, and iodine urine samples before and after the TAVI procedure.
1 visit at baseline and 3 follow-up visits at 4, 8, and 12 weeks
Duration - 1 month
Participants are monitored to assess the development of hypothyroidism and its impact on dependence level, cognitive function, depression, mobility, and daily living after the TAVI procedure.
2 visits at baseline and 1 month
Total: 1 location
1
UZ brussel
Brussels, Belgium, 1090
Actively Recruiting
N
nathalie Compté, Dr, PhD
B
Bert Bravenboer, Dr, PhD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Matthew L Stone, John A Kern, Robert M Sade
https://pubmed.ncbi.nlm.nih.gov/23176901Sergey Leontyev, Thomas Walther, Michael A Borger...
https://pubmed.ncbi.nlm.nih.gov/19379882Susheel K Kodali, Mathew R Williams, Craig R Smith...
https://pubmed.ncbi.nlm.nih.gov/22443479Angela M Leung, Lewis E Braverman
https://pubmed.ncbi.nlm.nih.gov/22820214Richard G Trohman, Parikshit S Sharma, Elizabeth A McAninch...
https://pubmed.ncbi.nlm.nih.gov/30309693